InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Mattes Glenn R., Chairman & CEO. Insider active across 1 company, notably TFF Pharmaceuticals, Inc.. Aggregated, 3 filings have been published. Split: 3 buys · 0 sell. Total volume traded: €194k. Activity tracked since 16 September 2021. The latest transaction was filed on 16 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
16,000 shares@ US$4.7837.8% of flowCommon StockSEC:0001213900-22-027791:0
Canonical exit: 14 Aug 2022 (T+90)
10,000 shares@ US$7.1031.1% of flowCommon StockSEC:0001213900-21-048369:0
Canonical exit: 15 Dec 2021 (T+90)
10,000 shares@ US$7.1031.1% of flowCommon StockSEC:0001213900-21-048369
Canonical exit: 15 Dec 2021 (T+90)
3 of 3 declarations
About Mattes Glenn R.
Glenn R. Mattes is the Chief Executive Officer of TFF Pharmaceuticals, Inc. He is responsible for the strategic and operational direction of the company, which focuses on developing innovative pharmaceutical solutions. Mattes is committed to advancing the company's mission.
